Norgine | Finanzwire

Basculer en Français

10491	Companies
221188	Keywords
150423	Articles
116989	Press releases

Home
Companies
Norgine

BRIEF

published on 05/05/2026 at 23:10, 28 days 1 hour ago

Norgine Secures TGA Approval for PEDMARQSI® in Australia

Childhood Cancer TGA Approval PEDMARQSI® Cisplatin Hearing Loss Norgine Pharmaceuticals
PRESS RELEASE

published on 05/05/2026 at 23:05, 28 days 1 hour ago

Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1
Norgine's PEDMARQSI(R) registered by TGA in Australia for preventing cisplatin-induced hearing loss in children. Approval addresses significant unmet medical need in paediatric oncology

Norgine PEDMARQSI TGA Registration Cisplatin-induced Hearing Loss Paediatric Oncology
BRIEF

published on 03/26/2026 at 07:10, 2 months 7 days ago

Swissmedic Approves PEDMARQSI® for Preventing Hearing Loss in Children

Swissmedic Approval Norgine PEDMARQSI® Children's Hearing Loss Cisplatin Chemotherapy
PRESS RELEASE

published on 03/26/2026 at 07:05, 2 months 7 days ago

Norgine announces Swissmedic approval of PEDMARQSI® for the prevention of cisplatin induced hearing loss in children
Norgine announces Swissmedic approval of PEDMARQSI(R) for the prevention of cisplatin induced hearing loss in children. PEDMARQSI(R) becomes the first treatment in Switzerland for this medical need

Children Swissmedic Approval Norgine PEDMARQSI Cisplatin Induced Hearing Loss
BRIEF

published on 02/27/2026 at 13:10, 3 months 3 days ago

Norgine Awaits European Commission's Decision on Mavorixafor for WHIM Syndrome

European Commission CHMP Opinion Norgine Mavorixafor WHIM Syndrome
PRESS RELEASE

published on 02/27/2026 at 13:05, 3 months 3 days ago

Norgine welcomes positive CHMP opinion recommending approval of mavorixafor in the European Union for WHIM syndrome
Norgine's mavorixafor receives positive CHMP opinion for WHIM syndrome treatment in the EU. Final EC decision expected in Q2 2026. Partnership with X4 Pharmaceuticals

CHMP Opinion Norgine Mavorixafor WHIM Syndrome X4 Pharmaceuticals

Accesswire

Published on 06/03/2026 at 00:00, 41 minutes ago

Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program
Published on 06/02/2026 at 22:30, 2 hours 11 minutes ago

INEO Announces Effective Date of Share Consolidation
Published on 06/02/2026 at 22:00, 2 hours 41 minutes ago

NYMOX Provides Current Update
Published on 06/02/2026 at 19:45, 4 hours 56 minutes ago

Announces Plans to Repurchase Common Shares
Published on 06/02/2026 at 19:40, 5 hours 1 minute ago

Taranis Outlines Four High-Priority Targets Around Thor and Thirty Prospects and Old Mines Located within 6,470 Ha Property

View all ACCESSWIRE

EQS Group

Published on 06/02/2026 at 22:35, 2 hours 5 minutes ago

Hycroft Delivers $10 Billion NPV from Technical Report at Spot Prices While Advancing High-Grade Brimstone and Vortex Silver Discoveries
Published on 06/02/2026 at 19:50, 4 hours 50 minutes ago

Recorded Future Announces Strategic Partnership with Wipro to Deliver AI-Powered Threat Intelligence at Global Enterprise Scale
Published on 06/02/2026 at 19:41, 4 hours 59 minutes ago

Avolta prices EUR 400 million of Senior Notes
Published on 06/02/2026 at 19:28, 5 hours 12 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/02/2026 at 18:24, 6 hours 17 minutes ago

Holding(s) in Company

Les Echos

Published on 06/02/2026 at 18:03, 6 hours 37 minutes ago

Total number of voting rights and shares making up the share capital at May 31, 2026
Published on 06/02/2026 at 17:42, 6 hours 59 minutes ago

Aéroports de Paris SA - Shares and voting rights as of 31 May 2026
Published on 06/02/2026 at 17:40, 7 hours 1 minute ago

Campus AI enters the implementation phase: Eiffage selected for deployment of shared infrastructure on the Fouju Campus in a deal worth over €120 million
Published on 06/02/2026 at 08:00, 16 hours 41 minutes ago

EURAZEO’S PRIVATE DEBT FUND CLOSES AT RECORD €3.9 BILLION, EXCEEDING ITS INITIAL TARGET
Published on 06/02/2026 at 07:30, 17 hours 11 minutes ago

OPmobility strengthens its U.S. footprint with a new state-of-the-art plant in the Midwest

View all LES ECHOS COMFI WIRE